KILITCH DRUGS (INDIA)
Back to All Ratios
|
KILITCH DRUGS (INDIA) Last 5 Year Cash Earnings per Share (CEPS) History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| CEPS(Rs) | 17.07 | 10.30 | 7.43 | 5.45 | 3.63 |
What is the latest Cash Earnings per Share (CEPS) ratio of KILITCH DRUGS (INDIA) ?
| Year | Cash Earnings per Share (CEPS) |
|---|---|
| Mar2025 | 17.07 |
| Mar2024 | 10.30 |
| Mar2023 | 7.43 |
| Mar2022 | 5.45 |
| Mar2021 | 3.63 |
How is Cash Earnings per Share (CEPS) of KILITCH DRUGS (INDIA) Trending?
| Years | Cash Earnings per Share (CEPS) | % Change | |
|---|---|---|---|
| Mar2025 | 17.07 | 65.73 | |
| Mar2024 | 10.3 | 38.63 | |
| Mar2023 | 7.43 | 36.33 | |
| Mar2022 | 5.45 | 50.14 | |
| Mar2021 | 3.63 | - | |
Other Financial Ratios of KILITCH DRUGS (INDIA)
| Operational & Financial Ratios Earnings Per Share DPS Book NAV/Share Tax Rate | Margin Ratios Core EBITDA Margin EBIT Margin Pre Tax Margin PAT Margin Cash Profit Margin | Performance Ratios ROA ROE ROCE Asset Turnover Sales/Fixed Asset Working Capital/Sales | Efficiency Ratios Fixed Capital/Sales Receivable days Inventory Days Payable days | Valuation Parameters PER PCE Price/Book Yield EV/Net Sales EV/Core EBITDA EV/EBIT EV/CE M Cap / Sales | Growth Ratios Net Sales Growth Core EBITDA Growth EBIT Growth PAT Growth EPS Growth | Financial Stability Ratios Total Debt/Equity Current Ratio Quick Ratio Interest Cover Total Debt/Mcap |
Compare Cash Earnings per Share (CEPS) ratio of peers of KILITCH DRUGS (INDIA)
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| KILITCH DRUGS (INDIA) | ₹577.2 Cr | 3.5% | -10.6% | 5.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹437,879.0 Cr | 1.5% | 6.9% | 13.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹166,620.0 Cr | -0.8% | 1.7% | 14% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹150,431.0 Cr | 3.2% | 9% | 44.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹110,070.0 Cr | 1.1% | 5% | 16.4% | Stock Analytics | |
| CIPLA | ₹107,051.0 Cr | 0.3% | -1.3% | -9% | Stock Analytics | |
KILITCH DRUGS (INDIA) Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| KILITCH DRUGS (INDIA) | 3.5% |
-10.6% |
5.2% |
| SENSEX | -5% |
-9.6% |
3.1% |
You may also like the below Video Courses